Achieve Life Sciences, Inc. (QUIT) short interest & options flow
NASDAQAchieve Life Sciences heads into its November 6 earnings date with a short book that has barely budged despite a 57% year-to-date rally, two activist 13D filers on the register, and a cytisinicline resubmission expected before year-end. Short interest is the defining feature of this stock right now. At 33.5% of the free float, it is one of the more heavily shorted small-cap…
ACHV utilization surges to 90.5%, highest level in two weeks, as short sellers tighten grip on available shares.
- Market cap
- $698M
- Next earnings
- 13 Nov 2026
Key data as of 10 Nov 2026
Latest signals on QUIT
- Utilization
ACHV utilization surges to 90.5%, highest level in two weeks, as short sellers tighten grip on available shares.
QUIT news and analysis
RSSNo long-form analysis yet for QUIT. Pulse alerts and the live data picture are available on ORTEX.
Open QUIT on ORTEX →Want the live picture for QUIT?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for QUIT — free to start on ORTEX.
Sign up for free →Open QUIT on ORTEX